← Eichor
Condition: Neurofilament Light Chain Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neurofilament Light Chain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery
NA · 1 location(s) · Poznan University of Medical Sciences · NCT07474909
Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.
NA · 1 location(s) · Floriana Costanzo · NCT07044804
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Mu
Phase 2 · 2 location(s) · Queen Mary University of London · NCT05418010
Novel Targetable BIOmarkers in ANorexia NervosA
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05885724
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
NA · 2 location(s) · Hôpital le Vinatier · NCT04946916
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
Phase N/A · 16 location(s) · Ambulanzpartner Soziotechnologie APST GmbH · NCT05852418
The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)
Phase N/A · 11 location(s) · University of Michigan · NCT04855396
Analysis of NfL and GFAP in Different Dietary Patterns
Phase N/A · 1 location(s) · Salzburger Landeskliniken · NCT07312994
Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Se
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT07353216
Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.
NA · 1 location(s) · Campus Bio-Medico University · NCT06834269
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Scl
Phase N/A · 28 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT03981003
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Phase 4 · 14 location(s) · Novartis Pharmaceuticals · NCT06733922
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Phase N/A · 2 location(s) · Monash University · NCT06339190
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisf
Phase N/A · 92 location(s) · Hoffmann-La Roche · NCT06780150
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)
Phase N/A · 1 location(s) · Imperial College London · NCT05885295
Multicenter ALS Imaging Study
Phase N/A · 3 location(s) · University of Minnesota · NCT06735014
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.